The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways 
Results
Oral treatment with BV suppressed airway inflammation through IL-10-dependent and MyD88-dependent mechanisms and induced the conversion of FoxP3-negative T cells into FoxP3-positive regulatory T cells. Furthermore, CD4-positive T cells purified from the trachea of BV-treated mice conferred protection against airway inflammation when adoptively transferred into sensitized mice.
Conclusion
Treatment with BV could possibly be a safe and efficient strategy to prevent the development of allergic disease in children.
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